 - Must have received and progressed during or following 1 prior chemotherapy regimen for metastatic disease not including an anti-androgen or ketoconazole; or, must have discontinued prior systemic therapy because of poor tolerance or other adverse effects; or, must have refused chemotherapy treatment. Patients having undergone more than 1 prior chemotherapy regimen may be admitted at the discretion of the sponsor. 